Pulmonary Disorders II
Acute Chronic Obstructive Pulmonary Disease
Exacerbation
Abroug F, Ouanes-Besbes L, Fkih-Hassen M, et
al. Prednisone in COPD exacerbation requiring
ventilatory support: an open-label randomised evalu-
ation. Eur Respir J. 2014;43(3):717-724. https://doi.
org/10.1183/09031936.00002913
Alía I, de la Cal MA, Esteban A, et al. Efficacy of corti-
costeroid therapy in patients with an acute exacerbation
of chronic obstructive pulmonary disease receiving
ventilatory support. Arch Intern Med. 2011;171(21):1939-
1946. https://doi.org/10.1001/archinternmed.2011.530
Austin MA, Wills KE, Blizzard L, Walters EH, Wood-
Baker R. Effect of high flow oxygen on mortality in
chronic obstructive pulmonary disease patients in pre-
hospital setting: randomised controlled trial. BMJ.
2010;341:c5462. https://doi.org/10.1136/bmj.c5462
Brochard L, Mancebo J, Wysocki M, et al. Noninvasive
ventilation for acute exacerbations of chronic obstructive
pulmonary disease. N Engl J Med. 1995;333(13):817-822.
https://doi.org/10.1056/nejm199509283331301
Celli BR, Fabbri LM, Aaron SD, et al. An updated defi-
nition and severity classification of chronic obstructive
pulmonary disease exacerbations: the Rome proposal.
https://doi.org/10.1164/rccm.202108-1819pp
Daubin C, Valette X, Thiollière F, et al. Procalcitonin
algorithm to guide initial antibiotic therapy in acute exac-
erbations of COPD admitted to the ICU: a randomized
437. https://doi.org/10.1007/s00134-018-5141-9
Domenech A, Puig C, Martí S, et al. Infectious etiol-
ogy of acute exacerbations in severe COPD patients.
J Infect. 2013;67(6):516-523. https://doi.org/10.1016/j.
jinf.2013.09.003
Echevarria C, Steer J, Wason J, Bourke S. Oxygen
therapy and inpatient mortality in COPD exacerba-
tion. Emerg Med J. 2021;38(3):170-177. https://doi.
org/10.1136/emermed-2019-209257
Fraser JF, Spooner AJ, Dunster KR, Anstey CM, Corley
A. Nasal high flow oxygen therapy in patients with
COPD reduces respiratory rate and tissue carbon dioxide
while increasing tidal and end-expiratory lung volumes:
a randomised crossover trial. Thorax. 2016;71(8):759-
761. https://doi.org/10.1136/thoraxjnl-2015-207962
Global Initiative for Chronic Obstructive Lung
Disease. Global strategy for the diagnosis, manage-
ment and prevention of COPD. 2024. https://goldcopd.
org/2024-gold-report/
Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D
to prevent exacerbations of COPD: systematic review
and meta-analysis of individual participant data from
randomised controlled trials. Thorax. 2019;74(4):337-
345. https://doi.org/10.1136/thoraxjnl-2018-212092
Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier
RW. Outcomes associated with corticosteroid dosage in
critically ill patients with acute exacerbations of chronic
Med.
2014;189(9):1052-1064.
https://doi.org/10.1164/
rccm.201401-0058oc
Kiser TH, Reynolds PM, Moss M, et al. Impact of mac-
rolide antibiotics on hospital readmissions and other
clinically important outcomes in critically ill patients
with acute exacerbations of chronic obstructive pulmo-
nary disease: a propensity score-matched cohort study.
2019;39(3):242-252.
https://doi.
org/10.1002/phar.2221
Leuppi JD, Schuetz P, Bingisser R, et al. Short-term vs con-
ventional glucocorticoid therapy in acute exacerbations
of chronic obstructive pulmonary disease: the REDUCE
2231. https://doi.org/10.1001/jama.2013.5023
Li L, Zhao N, Ma X, et al. Personalized variable vs fixed-
dose systemic corticosteroid therapy in hospitalized
patients with acute exacerbations of COPD: a prospec-
tive, multicenter, randomized, open-label clinical trial.
Chest. 2021;160(5):1660-1669. https://doi.org/10.1016/j.
chest.2021.05.024
Niewoehner DE, Erbland ML, Deupree RH, et al.
Effect of systemic glucocorticoids on exacerbations of
chronic obstructive pulmonary disease. Department of
Veterans Affairs Cooperative Study Group. N Engl J
Med. 1999;340(25):1941-1947. https://doi.org/10.1056/
nejm199906243402502
Rafiq R, Aleva FE, Schrumpf JA, et al. Vitamin D sup-
plementation in chronic obstructive pulmonary disease
patients with low serum vitamin D: a randomized con-
doi.org/10.1093/ajcn/nqac083
Ram FS, Rodriguez-Roisin R, Granados-Navarrete
A, Garcia-Aymerich J, Barnes NC. Antibiotics for